These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Psychological approach of adolescents with Crohn's disease]. Velin J; Kohon-Roujeau N Ann Pediatr (Paris); 1988 Nov; 35(9):665-7. PubMed ID: 3195969 [No Abstract] [Full Text] [Related]
3. [Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Hoffmann JC; Preiss JC; Autschbach F; Buhr HJ; Häuser W; Herrlinger K; Höhne W; Koletzko S; Krieglstein CF; Kruis W; Matthes H; Moser G; Reinshagen M; Rogler G; Schreiber S; Schreyer AG; Sido B; Siegmund B; Stallmach A; Bokemeyer B; Stange EF; Zeitz M Z Gastroenterol; 2008 Sep; 46(9):1094-146. PubMed ID: 18810679 [No Abstract] [Full Text] [Related]
4. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P Aliment Pharmacol Ther; 2005 Jul; 22(2):101-10. PubMed ID: 16011668 [TBL] [Abstract][Full Text] [Related]
5. Nutrition and Crohn's disease: an update of print and Web-based guidance. Moorthy D; Cappellano KL; Rosenberg IH Nutr Rev; 2008 Jul; 66(7):387-97. PubMed ID: 18667014 [TBL] [Abstract][Full Text] [Related]
6. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission. Sandborn WJ; Feagan BG; Lichtenstein GR Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506 [TBL] [Abstract][Full Text] [Related]
7. Australian Crohn's antibiotic study opens new horizons. Gitlin L; Biesecker J Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826 [No Abstract] [Full Text] [Related]
8. [Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases]. Stange EF; Schreiber S; Fölsch UR; von Herbay A; Schölmerich J; Hoffmann J; Zeitz M; Fleig WE; Buhr HJ; Kroesen AJ; Moser G; Matthes H; Adler G; Reinshagen M; Stein J; Z Gastroenterol; 2003 Jan; 41(1):19-20. PubMed ID: 12541167 [No Abstract] [Full Text] [Related]
10. The patient with Crohn's disease. Klonowski EI; Masoodi JE RN; 1999 Mar; 62(3):32-7; quiz 38. PubMed ID: 10205563 [No Abstract] [Full Text] [Related]
11. Smoking status in therapeutic trials in Crohn's disease. McGovern DP; Travis SP Gut; 2005 Jul; 54(7):1047-8. PubMed ID: 15951558 [No Abstract] [Full Text] [Related]
12. Biologic therapy in Crohn's disease: state of the art. Jones J; Panaccione R Curr Opin Gastroenterol; 2008 Jul; 24(4):475-81. PubMed ID: 18622162 [TBL] [Abstract][Full Text] [Related]
13. Importance of the Australian Crohn's disease antibiotic study. Chamberlin W Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827 [No Abstract] [Full Text] [Related]
14. Supporting the patient with Crohn's disease. Nursing grand rounds. Nursing; 1983 Nov; 13(11):46-51. PubMed ID: 6556478 [No Abstract] [Full Text] [Related]
15. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study. Kuenstner JT Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824 [No Abstract] [Full Text] [Related]
16. A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Rahimi R; Nikfar S; Rezaie A; Abdollahi M Clin Ther; 2006 Dec; 28(12):1983-8. PubMed ID: 17296455 [TBL] [Abstract][Full Text] [Related]
17. When the Dx is Crohn's disease. Meize-Grochowski AR RN; 1991 Feb; 54(2):52-6. PubMed ID: 1994470 [No Abstract] [Full Text] [Related]
18. Extracorporeal photochemotherapy for the treatment of refractory Crohn's disease. Bisaccia E; Palangio M; Gonzalez J Transfus Apher Sci; 2007 Oct; 37(2):171-4. PubMed ID: 17993292 [TBL] [Abstract][Full Text] [Related]
19. Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx". Rieder F; Hamer O; Gelbmann C; Schölmerich J; Gross V; Feuerbach S; Herfarth H; Rogler G Z Gastroenterol; 2006 Jul; 44(7):599-602. PubMed ID: 16823701 [TBL] [Abstract][Full Text] [Related]
20. Timing infliximab therapy in pediatric Crohn's disease. Kirschner BS; Huo D Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435 [No Abstract] [Full Text] [Related] [Next] [New Search]